PHARMACOLOGY

Pharmacology Track Faculty

 

William Clarke, Ph.D.

William Clarke, Ph.D.

Serotonin, Opioids, Estrogen, G protein coupled receptors, Schizophrenia, Depression, Anxiety, Pain, Functional Selectivity, Constitutive Receptor Activity, Receptor Theory

J. Thomas Cunningham, Ph.D.

J. Thomas Cunningham, Ph.D.

vasopressin, supraoptic nucleus, sympathetic nervous system, hypertension, hyponatremia, angiotensin, thirst, sodium appetite

Lynette C. Daws, Ph.D.

Lynette C. Daws, Ph.D.

Serotonin transporter, dopamine transporter, depression, stress, drug abuse, in vivo chronoamperometry

 

Franco B. Folli, M.D., Ph.D.

Franco B. Folli, M.D., Ph.D.

 molecular mechanisms of insulin resistance, Islets' of Langerhans amyloidosis, obesity, type 2 diabetes and insulin resistance syndrome, bariatric surgery

Charles France, Ph.D.

Charles France, Ph.D.

drug abuse, opioids, benzodiazepines, GHB, drug discrimination, self administration, dependence, withdrawal, neuropharmacology

Alan Frazer, Ph.D.

Alan Frazer, Ph.D.

antidepressants, norepinephrine, serotonin, transporters, vagal nerve stimulation

 

Lisa R. Gerak, Ph.D.

Lisa R. Gerak, Ph.D.

Benzodiazepines, neuroactive steroids, drug discrimination, dependence, withdrawal

Andrea Giuffrida, Ph.D.

Andrea Giuffrida, Ph.D.

cannabinoid, anandamide, dopamine, Parkinson disease, schizophrenia, dyskinesias

 

Julie Hensler, Ph.D.

Julie Hensler, Ph.D.

serotonin, brain derived neurotrophic factor (BDNF), depression, anxiety, behavior, stress

 

Syed Imam, Ph.D.

Syed Imam, Ph.D.

Parkinson's disease, Alzheimer's disease, Neurodegeneration, Cell Signaling, Oxidative Stress, Parkin, Tyrosine Kinases

Nathaniel Jeske, Ph.D.

Nathaniel Jeske, Ph.D.

pain, TRPV1, AKAP, inflammation, ECM

 

Charles Keller, M.D.

Charles Keller, M.D.

rhabdomyosarcoma, medulloblastoma, genetically engineered mice, satellite cell, muscle stem cell, receptor tyrosine kinase, preclinical therapeutics, small animal imaging

Wouter Koek, Ph.D.

Wouter Koek, Ph.D.

 drug abuse, alcohol, GHB, prescription drugs, drug discovery, antidepressants, behavioral pharmacology, drug discrimination

 

Yui-Wing Francis Lam

Yui-Wing Francis Lam, Pharm.D.

drug metabolism, clinical pharmacology, pharmacokinetics, pharmacogenetics

Senlin Li, M.D.

Senlin Li, M.D.

Parkinson's disease, neurodegenerative diseases, stem cell, iPS, hematopoietic stem cell, stem cell therapy, gene therapy, and altherosclerosis

 

Richard F. Ludueña, Ph.D.

Richard F. Ludueña, Ph.D.

structure of tubulin, biochemistry of microtubules, tubulin isotypes, mechanism of action of anti-tumor drugs

 

Steve Mifflin, Ph.D.

Steve Mifflin, Ph.D.

Neuroscience, electrophysiology, hypoxia, chemoreceptor

David Morilak, Ph.D.

David Morilak, Ph.D.

antidepressants, anxiety, behavior, cognition, depression, HPA axis, in situ hybridization, microdialysis, norepinephrine, PTSD, stress

 

Ravi Ranjan, Ph.D.

Ravi Ranjan, Ph.D.

neuroscience, synaptic plasticity, learning and memory, longevity, neurodegeneration, genetics, insulin, drosophila melanogaster

LuZhe Sun

LuZhe Sun, Ph.D.

Cell signaling, cancer biology, experimental therapy

 

Wei Zhang, M.D., Ph.D.

Wei Zhang, M.D., Ph.D.

Neurodegeneration, Neuroprotection, Parkinson's disease, leptin, Attractin